Strong evidence exists that reduced vascular reactivity is present in patients with heart failure, and that vascular function affects exercise capacity. The proposed studies will test the hypothesis that, in heart failure, intensive medical therapy and exercise training improve exercise- induced vascular reactivity by increasing bioavailability of endothelium- derived nitric oxide. First, the calf blood flow response to acetylcholine (an endothelium-dependent vasodilator), NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor), and nitroprusside (an endothelium-independent vasodilator) will be determined at rest and during isotonic exercise by venous occlusion plethysmography in heart failure patients. Second, oxygen uptake kinetics during sub-maximal and maximal leg exercise testing will be measured with breath-by-breath gas analysis and correlated with the leg vascular response to the above =-mentioned pharmacologic interventions. Finally, changes in leg blood flow response to acetylcholine, Ng- monomethyl-L-arginine, and nitroprusside will be determined before and after twelve weeks of leg exercise conditioning. These studies will lead to a greater understanding of clinically important vasomotor abnormalities in heart failure, and will determine th e potential for improvement in funcTIonal capacity after correction of vascular dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32HL009635-02
Application #
2735013
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1998-07-01
Project End
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Johnson, Wendy; Omland, Torbjorn; Hall, Christian et al. (2002) Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39:1623-9
Daniloff, J K; Crossin, K L; Pincon-Raymond, M et al. (1989) Expression of cytotactin in the normal and regenerating neuromuscular system. J Cell Biol 108:625-35